FDA Plants Oversight Flag On Amarin Trade Claim Against Omega-3 Ingredients

摘要

FDA Chief Counsel Rebecca Wood says Amarin's request for an ITC investigation necessarily turns on questions of drug and supplements policy, where it is the expert and authorized agency. If successful, Amarin's move could encourage others to similarly seek alternative forums for action.